लोड हो रहा है...
Mammalian target of rapamycin inhibition in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. It is associated with a poor prognosis and has limited treatment options. Sorafenib, a multi-targeted kinase inhibitor, is the only available systemic agent for treatment of HCC that improves overall survi...
में बचाया:
| में प्रकाशित: | World J Hepatol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243151/ https://ncbi.nlm.nih.gov/pubmed/25429315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i11.776 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|